Future oncology (London, England) · 2025
Enzalutamide treatment of patients with advanced prostate cancer across the disease spectrum: plain language review.
СтатьяОбзорНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Dato Paul E, De La Cerda Jose, Armstrong Andrew J, Azad Arun A, Conduit Ciara, Haas Gabriel P, Kernen Kenneth, Klaassen Zachary W, Patel Raj, Saad Fred, Shore Neal D, Freedland Stephen J, Karsh Lawrence I
Аннотация
GOAL: To present data from published clinical trials of treatment of patients with prostate cancer with enzalutamide described in plain language and in a dashboard format available at: https://clinical-trials.dimensions.ai/enzalutamide-clinical-review/.
RATIONALE: Treatments that are clinically active in advanced prostate cancer may benefit patients as they are treated earlier in the disease.
OBJECTIVE: To show how overall survival improves as patients are treated with enzalutamide earlier in the disease.
RATIONALE: Treatments that are clinically active in advanced prostate cancer may benefit patients as they are treated earlier in the disease.
OBJECTIVE: To show how overall survival improves as patients are treated with enzalutamide earlier in the disease.